Thiazolidinedione → 5-(3-Methyl-3H-benzotriazol-5-ylmethylene)-thiazolidine-2,4-dione

HRID 2261131Notes

Reaction equation

[CH3:1][N:2]1[C:6]2[CH:7]=[C:8]([CH:11]=O)[CH:9]=[CH:10][C:5]=2[N:4]=[N:3]1.[CH2:13]1[S:19][C:17](=[O:18])[NH:16][C:14]1=[O:15]>>[CH3:1][N:2]1[C:6]2[CH:7]=[C:8]([CH:11]=[C:13]3[S:19][C:17](=[O:18])[NH:16][C:14]3=[O:15])[CH:9]=[CH:10][C:5]=2[N:4]=[N:3]1

Participants

Reactant 2

HCID 5437Thiazolidinedione

HCID 18760799HCID 18760799, compound2×

Product 1

HCID 730971835-(3-Methyl-3H-benzotriazol-5-ylmethylene)-thiazolidine-2,4-dione

Procedure

Following the general method as outlined in Example 1, starting from 3-Methyl-3H-benzotriazole-5-carbaldehyde (intermediate 34) and thiazolidinedione, the title compound was obtained.

Sources & evidence

ORD record: ord-455a0f41962741b3bd729e1aaedf9d5b
Source dataset: uspto-grants-2010_12
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07846925B2

Reaction notes

Loading…